Angela Tang

发表

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

D. Boulton, C. Patel, E. Frevert, 2011, Clinical pharmacokinetics.

Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects

F. LaCreta, D. Boulton, Ming Chang, 2013, Clinical Drug Investigation.

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

F. LaCreta, D. Boulton, Angela Tang, 2011, Clinical drug investigation.

P0586 A COMPARISON OF THE SINGLE-DOSE PHARMACOKINETICS AND SAFETY OF SAXAGLIPTIN IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN HEALTHY SUBJECTS

D. Boulton, C. Patel, D. Kornhauser, 2009 .